Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$9.46
0.8610.00%
À la fermeture: -
$9.47
0.010000.11%
Après les heures de négociation: Oct 24, 7:54 PM EDT
Comments
Loading...
Évaluations des analystes, objectifs de prix, prévision
Teladoc Health Inc a un objectif de cours consensus de $14.31, basé sur les évaluations des 28 analystes. Le plus élevé est de $37 attribué par Oppenheimer le janvier 19, 2023, et le plus bas est de $7 attribué par B of A Securities le mai 28, 2025. Les 3 dernières évaluations d'analystes ont été publiées par Citigroup, Evercore ISI Group et Mizuho le octobre 21, 2025, octobre 8, 2025 et juillet 25, 2025. Avec un objectif de cours moyen de $9.83 entre Citigroup, Evercore ISI Group et Mizuho, il y a une variation implicite de 3.84% upside pour Teladoc Health Inc à partir de ces dernières évaluations d'analystes.
Sociétés d'analyse émettant des recommandations1
Citigroup
Evercore ISI Group
Mizuho
B of A Securities
Truist Securities
1calculé à partir des notes des analystes
Notes d'analystes pour Teladoc Health
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/21/2025 | 10.88% | Citigroup | $9.5 → $10.5 | Maintains | Neutral | |||
10/08/2025 | -4.96% | Evercore ISI Group | $8 → $9 | Maintains | In-Line | |||
07/25/2025 | 5.6% | Mizuho | → $10 | Initiates | → Neutral | |||
07/09/2025 | -15.52% | Evercore ISI Group | $7 → $8 | Maintains | In-Line | |||
05/28/2025 | -26.08% | B of A Securities | $8 → $7 | Maintains | Neutral | |||
05/27/2025 | -4.96% | Truist Securities | $10 → $9 | Maintains | Hold | |||
05/08/2025 | -15.52% | Wells Fargo | $10 → $8 | Maintains | Equal-Weight | |||
05/01/2025 | 26.72% | Canaccord Genuity | $14 → $12 | Maintains | Buy | |||
05/01/2025 | 5.6% | Goldman Sachs | $13 → $10 | Maintains | Buy | |||
05/01/2025 | -15.52% | Stifel | $9 → $8 | Maintains | Hold | |||
05/01/2025 | -26.08% | Evercore ISI Group | $8 → $7 | Maintains | In-Line | |||
05/01/2025 | — | Needham | — | Reiterates | Hold → Hold | |||
04/25/2025 | -7.6% | Citigroup | $11 → $8.75 | Maintains | Neutral | |||
04/21/2025 | -15.52% | Jefferies | $10 → $8 | Maintains | Hold | |||
04/11/2025 | -15.52% | B of A Securities | $9.5 → $8 | Maintains | Neutral | |||
03/03/2025 | 37.28% | Goldman Sachs | $16 → $13 | Maintains | Buy | |||
02/27/2025 | — | Needham | — | Reiterates | Hold → Hold | |||
02/27/2025 | 26.72% | Piper Sandler | $13 → $12 | Maintains | Overweight | |||
02/18/2025 | 68.95% | Goldman Sachs | $14 → $16 | Maintains | Buy | |||
02/12/2025 | 42.56% | B of A Securities | $11.5 → $13.5 | Maintains | Neutral | |||
02/06/2025 | 21.44% | B of A Securities | $10.5 → $11.5 | Maintains | Neutral | |||
01/24/2025 | 26.72% | RBC Capital | $11 → $12 | Maintains | Outperform | |||
01/24/2025 | 26.72% | Oppenheimer | $14 → $12 | Maintains | Outperform | |||
12/04/2024 | 37.28% | Piper Sandler | $11 → $13 | Reiterates | Overweight → Overweight | |||
11/15/2024 | 47.84% | Goldman Sachs | → $14 | Initiates | → Buy | |||
11/01/2024 | 26.72% | Deutsche Bank | $10 → $12 | Maintains | Hold | |||
10/31/2024 | 26.72% | Barclays | $10 → $12 | Maintains | Overweight | |||
10/31/2024 | -15.52% | TD Cowen | $9 → $8 | Maintains | Hold | |||
10/09/2024 | 5.6% | RBC Capital | $9 → $10 | Maintains | Outperform | |||
10/08/2024 | -4.96% | Evercore ISI Group | $8 → $9 | Maintains | In-Line | |||
09/17/2024 | 5.6% | Jefferies | $8 → $10 | Maintains | Hold | |||
08/26/2024 | -4.96% | JP Morgan | $16 → $9 | Maintains | Neutral | |||
08/20/2024 | 5.6% | Cantor Fitzgerald | $10 → $10 | Reiterates | Overweight → Overweight | |||
08/06/2024 | 5.6% | Piper Sandler | $25 → $10 | Maintains | Overweight | |||
08/02/2024 | 5.6% | Deutsche Bank | $15 → $10 | Maintains | Hold | |||
08/02/2024 | 5.6% | Truist Securities | $15 → $10 | Maintains | Hold | |||
08/01/2024 | — | Needham | — | Reiterates | → Hold | |||
08/01/2024 | -4.96% | TD Cowen | $15 → $9 | Maintains | Hold | |||
08/01/2024 | -4.96% | RBC Capital | $18 → $9 | Maintains | Outperform | |||
08/01/2024 | 5.6% | Barclays | $20 → $10 | Maintains | Overweight | |||
08/01/2024 | -4.96% | Stifel | $16 → $9 | Maintains | Hold | |||
08/01/2024 | -15.52% | DA Davidson | $12 → $8 | Maintains | Neutral | |||
08/01/2024 | 79.51% | Canaccord Genuity | $25 → $17 | Maintains | Buy | |||
08/01/2024 | 79.51% | Oppenheimer | $21 → $17 | Maintains | Outperform | |||
07/09/2024 | 5.6% | Evercore ISI Group | $14 → $10 | Maintains | In-Line | |||
05/21/2024 | 68.95% | JP Morgan | $19 → $16 | Maintains | Neutral | |||
05/20/2024 | 47.84% | Jefferies | $16 → $14 | Maintains | Hold | |||
05/14/2024 | 42.56% | B of A Securities | $16.5 → $13.5 | Maintains | Neutral | |||
04/29/2024 | 58.39% | Wells Fargo | $17 → $15 | Maintains | Equal-Weight | |||
04/26/2024 | 121.75% | Oppenheimer | $26 → $21 | Maintains | Outperform | |||
04/26/2024 | 58.39% | TD Cowen | $16 → $15 | Maintains | Hold | |||
04/26/2024 | 47.84% | Evercore ISI Group | — | $15 → $14 | Maintains | In-Line | ||
04/26/2024 | 90.07% | RBC Capital | $25 → $18 | Maintains | Outperform | |||
04/26/2024 | 68.95% | Stifel | $21 → $16 | Maintains | Hold | |||
04/26/2024 | 111.19% | Barclays | $25 → $20 | Maintains | Overweight | |||
04/26/2024 | 163.99% | Canaccord Genuity | $28 → $25 | Maintains | Buy | |||
04/26/2024 | — | Needham | — | Reiterates | → Hold | |||
04/05/2024 | — | Needham | — | Reiterates | → Hold | |||
03/06/2024 | 79.51% | Truist Securities | $23 → $17 | Maintains | Hold | |||
02/29/2024 | 132.31% | Cantor Fitzgerald | → $22 | Initiates | → Overweight | |||
02/26/2024 | 79.51% | Leerink Partners | → $17 | Initiates | → Market Perform | |||
02/21/2024 | 90.07% | DA Davidson | $22 → $18 | Maintains | Neutral | |||
02/21/2024 | 100.63% | Citigroup | $21 → $19 | Maintains | Neutral | |||
02/21/2024 | 163.99% | RBC Capital | $30 → $25 | Maintains | Outperform | |||
02/21/2024 | 163.99% | Barclays | $26 → $25 | Maintains | Overweight | |||
02/21/2024 | 163.99% | Piper Sandler | $30 → $25 | Maintains | Overweight | |||
02/21/2024 | 195.67% | Canaccord Genuity | $34 → $28 | Maintains | Buy | |||
11/17/2023 | 100.63% | JP Morgan | $33 → $19 | Maintains | Neutral | |||
10/25/2023 | 216.79% | RBC Capital | $35 → $30 | Maintains | Outperform | |||
10/25/2023 | 174.55% | Oppenheimer | $35 → $26 | Maintains | Outperform | |||
10/23/2023 | 121.75% | Citigroup | $29 → $21 | Maintains | Neutral | |||
10/20/2023 | 121.75% | Citigroup | $29 → $21 | Maintains | Neutral | |||
09/25/2023 | 195.67% | Truist Securities | → $28 | Reiterates | Hold → Hold | |||
07/26/2023 | 195.67% | Stephens & Co. | → $28 | Reiterates | Equal-Weight → Equal-Weight | |||
07/26/2023 | 269.59% | RBC Capital | → $35 | Reiterates | Outperform → Outperform | |||
07/26/2023 | 206.23% | Citigroup | $31 → $29 | Maintains | Neutral | |||
07/26/2023 | 185.11% | Credit Suisse | → $27 | Reiterates | Neutral → Neutral | |||
04/28/2023 | 206.23% | Deutsche Bank | $27 → $29 | Maintains | Hold | |||
04/27/2023 | 227.35% | Citigroup | $30 → $31 | Maintains | Neutral | |||
04/27/2023 | 269.59% | RBC Capital | → $35 | Reiterates | → Outperform | |||
04/27/2023 | 185.11% | Credit Suisse | → $27 | Reiterates | → Neutral | |||
04/27/2023 | 206.23% | Barclays | $28 → $29 | Maintains | Equal-Weight | |||
04/12/2023 | 163.99% | Stephens & Co. | → $25 | Initiates | → Equal-Weight | |||
03/10/2023 | 185.11% | Credit Suisse | $30 → $27 | Maintains | Neutral | |||
03/06/2023 | 280.15% | Canaccord Genuity | $40 → $36 | Maintains | Buy | |||
03/06/2023 | 142.87% | Wells Fargo | $28 → $23 | Maintains | Equal-Weight | |||
02/28/2023 | 216.79% | Citigroup | $33 → $30 | Maintains | Neutral | |||
02/27/2023 | 185.11% | Deutsche Bank | $31 → $27 | Maintains | Hold | |||
02/27/2023 | 248.47% | JP Morgan | $35 → $33 | Maintains | Neutral | |||
02/23/2023 | 269.59% | Oppenheimer | $37 → $35 | Maintains | Outperform | |||
02/23/2023 | 269.59% | RBC Capital | → $35 | Reiterates | → Outperform | |||
02/23/2023 | 259.03% | SVB Leerink | → $34 | Upgrade | Market Perform → Outperform | |||
01/19/2023 | 290.71% | Oppenheimer | $45 → $37 | Maintains | Outperform | |||
01/18/2023 | 195.67% | Barclays | $32 → $28 | Maintains | Equal-Weight | |||
12/13/2022 | 248.47% | Citigroup | $36 → $33 | Maintains | Neutral | |||
10/31/2022 | 216.79% | Credit Suisse | $35 → $30 | Maintains | Neutral | |||
10/27/2022 | 280.15% | Citigroup | $38 → $36 | Maintains | Neutral | |||
10/27/2022 | 237.91% | Barclays | $33 → $32 | Maintains | Equal-Weight |
FAQ
Quel est le cours indicatif de l'action Teladoc Health (TDOC) ?
Le dernier objectif de prix pour Teladoc Health (NYSE:TDOC) a été rapporté par Citigroup le octobre 21, 2025. Le cabinet d'analystes a fixé un objectif de prix pour $10.50 s'attendant à ce que TDOC se rise dans les 12 prochains mois (un possible changement de 10.88% upside). 28 cabinets d'analystes ont rapporté des notes au cours de la dernière année.
Quelle est la note d'analyste la plus récente pour Teladoc Health (TDOC) ?
La dernière note d'analyste pour Teladoc Health (NYSE:TDOC) a été fournie par Citigroup, et Teladoc Health maintenu leur note neutral.
Quand a eu lieu la dernière mise à niveau pour Teladoc Health (TDOC) ?
La dernière amélioration pour Teladoc Health Inc a eu lieu le février 23, 2023 lorsque SVB Leerink a augmenté leur objectif de prix à $34. SVB Leerink avait précédemment a market perform pour Teladoc Health Inc.
Quand a eu lieu la dernière dégradation pour Teladoc Health (TDOC) ?
Il n'y a pas de dernière réduction pour Teladoc Health.
Quand la prochaine note d'analyste sera-t-elle publiée ou mise à jour pour Teladoc Health (TDOC) ?
Les analystes arrivent à des évaluations d'actions après avoir effectué des recherches approfondies, ce qui inclut l'examen des états financiers publics, la discussion avec les dirigeants et les clients de Teladoc Health, et l'écoute des conférences téléphoniques sur les résultats. La plupart des analystes font cela tous les trois mois, vous devriez donc obtenir 4 notes par entreprise par société chaque année. La dernière note pour Teladoc Health a été déposée le octobre 21, 2025, donc vous devriez vous attendre à ce que la prochaine note soit disponible vers octobre 21, 2026.
La note d'analyste pour Teladoc Health (TDOC) est-elle correcte ?
Bien que les évaluations soient subjectives et changeront, la dernière note de Teladoc Health (TDOC) était un maintenu avec un objectif de prix de $9.50 à $10.50. Le prix actuel de Teladoc Health (TDOC) est de $9.47, ce qui est out of la fourchette prédite par l'analyste.
Parcourir notes d'analystes et objectifs de cours sur toutes les actions.